InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by Perlman Andrew J, 董事. Officer active across 1 company, notably Arcus Biosciences, Inc.. In total, 6 filings have been recorded. History available since 3 June 2021. The latest transaction was disclosed on 10 June 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Perlman Andrew J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
5,700 股Common StockSEC:0001201617-26-000003:0
13,300 股0Common StockSEC:0001724521-25-000092:0
8,400 股0Common StockSEC:0001724521-24-000112:0
6,800 股0Common StockSEC:0001209191-23-038148:0
4,100 股0Common StockSEC:0001209191-22-037438:0
3,000 股0Common StockSEC:0001209191-21-038635:0
6 条申报中的 6 条
About Perlman Andrew J
Andrew J. Perlman serves as a Board Member at Arcus Biosciences, Inc. In this role, he is involved in overseeing the company's operations and in strategic decision-making. His experience in corporate governance helps guide the company towards its development goals.
